To conclude, ECM biomarkers are helpful in identifying patients at risk of relevant graft fibrosis. Drug Deliv. PLoS One 10 , e Fibrosis is the result of accelerated accumulation of extracellular matrix ECM proteins, in particular interstitial types I, III, and V collagens that increase up to 6-fold in advanced liver fibrosis 6. Biometrics 44 , —
nest...